Aisling Capital Partners III LLC is Director & 10% Owner at Loxo Oncology, Inc. (LOXO). They have made 6 open-market trades across 3 companies since 2012, most recently 2017-12-19.
CIK 0001532635
5 open-market purchases totalling $27.2M since 2012, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LOXO | SELL | 2017-12-19 | 2017-12-20 | $80.50 | $20.1M | +4.6% | +19.6% | +50.6% |
| LOXO | BUY | 2016-05-17 | 2016-05-19 | $21.50 | $5.0M | +5.7% | -8.6% | -2.9% |
| TTOO | BUY | 2015-12-09 | 2015-12-09 | $9.75 | $3.0M | -22.2% | -7.7% | -16.4% |
| LOXO | BUY | 2015-11-17 | 2015-11-19 | $26.50 | $7.0M | -23.5% | -1.3% | -30.9% |
| LOXO | BUY | 2015-11-12 | 2015-11-16 | $27.65 | $2.2M | -23.5% | -1.3% | -35.1% |
| DRTX | BUY | 2012-07-24 | 2012-07-25 | $9.00 | $10.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.